Interview with Marta Milà Alomà

Could you tell us a bit about you and your work? My background lies in the fields of neurobiology and neuropsychology, and I am currently a PhD student at Barcelonabeta Brain Research Center. My research focuses on the study of fluid biomarker profiles in preclinical Alzheimer’s disease, as well as on the effect of modifiable…

New paper on the EPAD participant panel experience

On 15 October, a new paper entitled “Involving research participants in a pan-European research initiative: the EPAD participant panel experience” has been published in the journal Research Involvement and Engagement. One of the founding goals of the EPAD programme was to involve participants as research partners. EPAD set up a series of ‘participant panels’ in…

EPAD publishes a new paper on cognitive dispersion

The EPAD team has published a new paper entitled “Cognitive Dispersion is not Associated with Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Results from the European Prevention of Alzheimer’s Dementia (EPAD) v500.0 Cohort” in the journal of Alzheimer’s disease. Abstract: Background: Cognitive dispersion, variation in performance across cognitive domains, is posited as a non-invasive and cost-effective…

New ERC starting grant to identify age-related human blood factors as a therapeutic target for Alzheimer’s disease

The European Research Council has awarded an Early Career Research (ERC) starting grant to the neurologist Marc Suárez-Calvet, MD, PhD, who will use data from the EPAD Longitudinal Cohort Study for his new project entitled “Identification of age-related Human Blood factors as a therapeutic target for Alzheimer’s disease” (acronym: HeBe). The overall aim of the…

EPAD members report on important advances and progress

The past years were very productive and efficient for the EPAD project. In this piece, we wanted to reflect back on some of the important advances and major achievements made by each Work Package (WP). WP1 (Scientific challenges) Creation of 5 Scientific Advisory Groups (SAGs) – Clinical and Cognitive Outcomes, Fluid Biomarkers, Genetics, Imaging and…

Interview with John Harrison

Could you tell us a bit about you? I am an expert psychologist with a special interest in cognition and its measurement. I have recently been appointed Chief Science Officer at Neurotrack and am Principal Consultant at Metis Cognition, a psychology practice established to advise with the selection and successful integration of cognitive testing into…

Craig Ritchie wins 2020 William Farr Medal

We are pleased to inform you that the 2020 William Farr Medal of the Worshipful Society of Apothecaries was awarded to our Project Co-coordinator Craig Ritchie in recognition of the substantial impact made at a global level on the wellbeing of older people through leadership of dementia prevention research and service innovation, merging expertise in…

Lucy Stirland wins 2020 Porto Research Award

Lucy Stirland has been awarded the 2020 Porto Research Award from the European Federation of Psychiatric Trainees (EFPT) for her paper using EPAD V500.0 data, published last year in the Journal of Alzheimer’s Disease. The aims of this award are to encourage psychiatric trainees to conduct research and contribute to the engagement of psychiatry trainees…